John Nicols - Apr 17, 2023 Form 4 Insider Report for CODEXIS, INC. (CDXS)

Role
Director
Signature
/s/ Sriram Ryali, as Attorney-in-Fact for John J. Nicols
Stock symbol
CDXS
Transactions as of
Apr 17, 2023
Transactions value $
-$158,538
Form type
4
Date filed
4/19/2023, 04:18 PM
Previous filing
Mar 17, 2023
Next filing
Jul 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDXS Common Stock Options Exercise $70.4K +35.7K +4.56% $1.97 820K Apr 17, 2023 Direct F1
transaction CDXS Common Stock Sale -$151K -35.7K -4.36% $4.24 784K Apr 17, 2023 Direct F1, F2
transaction CDXS Common Stock Options Exercise $70.4K +35.7K +4.56% $1.97 820K Apr 18, 2023 Direct F1
transaction CDXS Common Stock Sale -$148K -35.7K -4.36% $4.14 784K Apr 18, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDXS Stock Option (Right to Buy) Options Exercise $0 -35.7K -16.67% $0.00 179K Apr 17, 2023 Common Stock 35.7K $1.97 Direct F1
transaction CDXS Stock Option (Right to Buy) Options Exercise $0 -35.7K -20% $0.00 143K Apr 18, 2023 Common Stock 35.7K $1.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022.
F2 This transaction was executed in multiple trades in prices ranging from $4.08 to $4.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 This transaction was executed in multiple trades in prices ranging from $4.055 to $4.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.